1,092 results on '"Sifrim, Daniel"'
Search Results
52. Actualización en la fisiopatología de la enfermedad por reflujo gastroesofágico
53. Effect of hiatus hernia on reflux patterns and mucosal integrity in patients with non‐erosive reflux disease
54. Knowledge gaps in the management of refractory reflux‐like symptoms: Healthcare provider survey
55. Tu1141: ROLE OF THE PEPSIN IN THE PULMONARY INFLAMMATORY DYSFUNCTION INDUCED BY GASTROESOPHAGEAL REFLUX IN MICE.
56. Su1210: RNA SEQUENCING REVEALS FEW MOLECULAR DIFFERENCES IN OESOPHAGEAL MUCOSA BETWEEN PATIENTS WITH EROSIVE AND NON-EROSIVE REFLUX DISEASE
57. Mo1174: NOVEL ARTIFICIAL INTELLIGENCE PROGRAM USING CONVOLUTIONAL NEURAL NETWORK IDENTIFIES SUPRAGASTRIC BELCHING ON PHIMPEDANCE STUDIES
58. Su1200: ESOPHAGEAL MUCOSAL AND MOLECULAR DIFFERENCES BETWEEN FUNCTIONAL HEARTBURN AND HEALTHY ASYMPTOMATIC SUBJECTS
59. Sa1192: MANAGEMENT OF REFRACTORY GERD SYMPTOMS IN EUROPE: EXPERT OPINION IN A CASE-BASED DELPHI APPROACH
60. Tu1142: RELATIONSHIP BETWEEN SUPRA-GASTRIC BELCHING, INEFFECTIVE ESOPHAGEAL MOTILITY AND ESOPHAGEAL ACID EXPOSURE IN PATIENTS WITH REFLUX LIKE SYMPTOMS
61. EP1124: IN NERD PATIENTS WITH SIMILAR ACID BURDEN, THE PRESENCE OF HIATAL HERNIA INDEPENDENTLY IMPAIRED DISTAL ESOPHAGEAL MUCOSAL INTEGRITY, PRESUMABLY THROUGH EXCESSIVE BILE REFLUX
62. Su1108: ASSESSING KNOWLEDGE GAPS IN THE MANAGEMENT OF REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE (RGERD)
63. 1079: COMPARED TO HEALTHY SUBJECTS, ESOPHAGEAL MUCOSA FROM PATIENTS WITH GASTRO-OESOPHAGEAL REFLUX DISEASE HAVE INCREASED NERVE GROWTH FACTOR-RELEASING MAST CELLS, AND FEWER DENDRITIC CELLS
64. Increased Prandial Air Swallowing and Postprandial Gas-Liquid Reflux Among Patients Refractory to Proton Pump Inhibitor Therapy
65. Emerging therapeutic options in GERD
66. Mo1294 PRIMARY PERISTALSIS IS THE DOMINANT MECHANISM OF PH RECOVERY FOLLOWING GASTROESOPHAGEAL REFLUX REGARDLESS OF TIMING AFTER REFLUX
67. The influence of supragastric belching severity on esophageal acid exposure and motility.
68. Laryngeal and Esophageal Mucosal Protection Using the Angico Gum Biopolymer in a Mouse Model of Reflux
69. Solid bolus swallows during high‐resolution manometry complement multiple rapid swallows in predicting symptoms following antireflux surgery
70. New Pharmacologic Approaches in Gastroesophageal Reflux Disease
71. Management of supragastric belching
72. Editorial: rumination—more frequent than previously thought
73. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management
74. Functional Esophageal Disorders: Pharmacological Options
75. Laryngeal and Esophageal Mucosal Protection Using the Angico Gum Biopolymer in a Mouse Model of Reflux.
76. Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease
77. Long-term Outcome of Pneumatic Dilation in the Treatment of Achalasia
78. The refluxate: The impact of its magnitude, composition and distribution
79. Pathophysiology of Pediatric Gastroesophageal Reflux Disease
80. Chicago Classification of Esophageal Motility Disorders: Applications and Limits in Adults and Pediatric Patients with Esophageal Symptoms
81. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease
82. Cough and gastroesophageal reflux: From the gastroenterologist end
83. Efficacy of the Long-Acting Repeatable Formulation of the Somatostatin Analogue Octreotide in Postoperative Dumping
84. Utility of non-endoscopic investigations in the practical management of oesophageal disorders
85. Oropharyngeal Dysphagia and Swallowing Dysfunction
86. Editorial: inconclusive diagnosis of GERD—are new parameters in impedance‐pH‐metry ready for clinical use?
87. Reply
88. Belching in children: Prevalence and association with gastroesophageal reflux disease
89. Esophageal mucosal sensory nerves and potential mechanoreceptors in patients with ineffective esophageal motility
90. 693 ESOPHAGEAL MUCOSA SENSORY NERVES AND POTENTIAL MECHANORECEPTORS IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY
91. Su409 BELCHING IN CHILDREN: PREVALENCE AND ASSOCIATION WITH GASTROESOPHAGEAL REFLUX DISEASE
92. 789 HEARTBURN SENSATION IN NON-EROSIVE REFLUX DISEASE: DISTINCTIVE PATTERN OF SUPERFICIAL SENSORY NERVES EXPRESSING TRPV1 AND EPITHELIAL CELLS EXPRESSING ASIC3 RECEPTORS
93. Sa152 THRESHOLDS FOR REFLUX METRICS ON PH-IMPEDANCE MONITORING PERFORMED 'ON’ BID PROTON PUMP INHIBITOR (PPI) THERAPY: MULTICENTER INTERNATIONAL COLLABORATIVE STUDY
94. Heartburn sensation in nonerosive reflux disease: pattern of superficial sensory nerves expressing TRPV1 and epithelial cells expressing ASIC3 receptors
95. Sa151 ARTIFICIAL INTELLIGENCE AUTOMATES IDENTIFICATION OF SUPRAGASTRIC BELCHING WITH ACCURACY COMPARATIVE TO EXPERT MANUAL REVIEW
96. Relevance of GERD in Lung Transplant Patients
97. Oesophageal shortening: in vivo validation of high-frequency ultrasound measurements of oesophageal muscle wall thickness
98. Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus
99. GERD: Body position affects infant GER but not symptoms
100. Oesophageal mucosal barrier: a key factor in the pathophysiology of non-erosive reflux disease (NERD) and a potential target for treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.